NTRK1 and melanoma: On the other hand, adhesion of BRAF mutant melanoma cells to ECM generated from MAF confers resistance to TT via the tyrosine kinase receptors for collagens DDR1 and DDR2 and activation of a NIK/NFkB2 survival pathway [72].